PharMerica Sustainability Profile
PharMerica Corporation, a leading provider of pharmacy services, is headquartered in the United States and operates extensively across various regions. Founded in 2000, the company has established itself within the healthcare industry, focusing primarily on long-term care and institutional pharmacy services. PharMerica offers a range of core services, including medication management, consulting, and clinical pharmacy solutions, which are tailored to meet the unique needs of its clients. The company is recognised for its commitment to enhancing patient care through innovative pharmacy practices and technology integration. With a strong market position, PharMerica has achieved notable milestones, including strategic partnerships and expansions that have solidified its reputation as a trusted pharmacy provider in the long-term care sector.
DitchCarbon Score
How does PharMerica's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PharMerica's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PharMerica's reported carbon emissions
PharMerica, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of PharMerica Corporation and does not report any reduction targets or climate pledges at this time. As a part of the broader healthcare sector, PharMerica's climate commitments may align with industry standards, but specific initiatives or targets have not been disclosed. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the absence of specific metrics, it is essential for PharMerica to establish clear carbon reduction goals and report on emissions to enhance transparency and accountability in its environmental impact.
How Carbon Intensive is PharMerica's Industry?
How Carbon Intensive is PharMerica's Location?
PharMerica's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PharMerica has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
